Paper366756
Assessment of response and recurrence in breast cancer.
Hayward JL and 2 others. Semin Oncol, 1978. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Assessment of response and recurrence in breast cancer. Papers, record 366756. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/366756
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Recurrence | |
| Research Design | |
| Therapeutics | |
| Time Factors |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 20859353 | Phase II Trial of a Novel Paclitaxel Schedule As Single-Agent, First-Line Therapy for HER-2/neu-Negative Metastatic Breast Cancer: A Community-Based Study. | J Oncol Pract | 2006 | https://conductscience.org/library/papers/20859353 | PubMed |
| 12065263 | Stressful life experiences and risk of relapse of breast cancer: observational cohort study. | BMJ | 2002 | https://conductscience.org/library/papers/12065263 | PubMed |
| 10098755 | A high incidence of vertebral fracture in women with breast cancer. | Br J Cancer | 1999 | https://conductscience.org/library/papers/10098755 | PubMed |
| 8912543 | Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8912543 | PubMed |
| 3697513 | Response to endocrine therapy and breast cancer differentiation. | Breast Cancer Res Treat | 1986 | https://conductscience.org/library/papers/3697513 | PubMed |
| 2849974 | An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma. | Br J Cancer | 1988 | https://conductscience.org/library/papers/2849974 | PubMed |
| 2493899 | Stress and relapse of breast cancer. | BMJ | 1989 | https://conductscience.org/library/papers/2493899 | PubMed |
| 1873550 | Recurrence and survival rates in British and Japanese women with breast cancer. | Breast Cancer Res Treat | 1991 | https://conductscience.org/library/papers/1873550 | PubMed |
| 1873549 | Patterns of recurrence and relapse--Anglo-Japanese comparative study. | Breast Cancer Res Treat | 1991 | https://conductscience.org/library/papers/1873549 | PubMed |
| 1764379 | Verification of the cause of death in the trial of early detection of breast cancer. UK Trial of Early Detection of Breast Cancer Group. Trial Co-ordinating Centre. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1764379 | PubMed |
| 1391992 | A comparison of all-subset Cox and accelerated failure time models with Cox step-wise regression for node-positive breast cancer. | Breast Cancer Res Treat | 1992 | https://conductscience.org/library/papers/1391992 | PubMed |
| 1333787 | Expression of the ERBB3 gene product in breast cancer. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1333787 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/366756
GET https://conductscience.org/api/papers/v1/366756/authors